FI106554B - Menetelmä terapeuttisesti käyttökelpoisten WS7622A-mono- tai disulfaatin valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten WS7622A-mono- tai disulfaatin valmistamiseksi Download PDF

Info

Publication number
FI106554B
FI106554B FI912914A FI912914A FI106554B FI 106554 B FI106554 B FI 106554B FI 912914 A FI912914 A FI 912914A FI 912914 A FI912914 A FI 912914A FI 106554 B FI106554 B FI 106554B
Authority
FI
Finland
Prior art keywords
ws7622a
disulfate
salt
amino acid
methanol
Prior art date
Application number
FI912914A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI912914L (fi
FI912914A0 (fi
Inventor
Nobuharu Shigematsu
Masakuni Okuhara
Masami Ezaki
Shigehiro Takase
Hiroshi Hatanaka
Masanori Okamoto
Eisaku Tsujii
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI912914A0 publication Critical patent/FI912914A0/fi
Publication of FI912914L publication Critical patent/FI912914L/fi
Application granted granted Critical
Publication of FI106554B publication Critical patent/FI106554B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
FI912914A 1990-06-29 1991-06-17 Menetelmä terapeuttisesti käyttökelpoisten WS7622A-mono- tai disulfaatin valmistamiseksi FI106554B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof
GB9014546 1990-06-29

Publications (3)

Publication Number Publication Date
FI912914A0 FI912914A0 (fi) 1991-06-17
FI912914L FI912914L (fi) 1991-12-30
FI106554B true FI106554B (fi) 2001-02-28

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912914A FI106554B (fi) 1990-06-29 1991-06-17 Menetelmä terapeuttisesti käyttökelpoisten WS7622A-mono- tai disulfaatin valmistamiseksi

Country Status (22)

Country Link
US (2) US5292510A (de)
EP (1) EP0465895B1 (de)
JP (1) JP2663763B2 (de)
KR (1) KR100198693B1 (de)
CN (1) CN1073115C (de)
AT (1) ATE138074T1 (de)
AU (1) AU640241B2 (de)
CA (1) CA2045761C (de)
DE (1) DE69119488T2 (de)
DK (1) DK0465895T3 (de)
ES (1) ES2087178T3 (de)
FI (1) FI106554B (de)
GB (1) GB9014546D0 (de)
GR (1) GR3020184T3 (de)
HU (1) HU213398B (de)
IE (1) IE75702B1 (de)
IL (1) IL98394A (de)
NO (1) NO301643B1 (de)
PH (1) PH31239A (de)
PT (1) PT98134B (de)
RU (1) RU2087482C1 (de)
ZA (1) ZA914349B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2111013T3 (es) * 1991-06-18 1998-03-01 Fujisawa Pharmaceutical Co Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
US6610748B1 (en) * 1998-02-24 2003-08-26 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心） 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
IE912047A1 (en) 1992-01-01
KR920000920A (ko) 1992-01-29
AU7939491A (en) 1992-01-09
HU912198D0 (en) 1991-12-30
RU2087482C1 (ru) 1997-08-20
GR3020184T3 (en) 1996-09-30
PT98134B (pt) 1998-12-31
NO912561L (no) 1991-12-30
CN1057655A (zh) 1992-01-08
FI912914L (fi) 1991-12-30
PT98134A (pt) 1992-06-30
US5364624A (en) 1994-11-15
EP0465895A1 (de) 1992-01-15
NO301643B1 (no) 1997-11-24
IL98394A0 (en) 1992-07-15
DE69119488D1 (de) 1996-06-20
ATE138074T1 (de) 1996-06-15
ZA914349B (en) 1992-03-25
JP2663763B2 (ja) 1997-10-15
US5292510A (en) 1994-03-08
CA2045761A1 (en) 1991-12-30
HU213398B (en) 1997-06-30
IL98394A (en) 1995-03-30
IE75702B1 (en) 1997-09-10
AU640241B2 (en) 1993-08-19
EP0465895B1 (de) 1996-05-15
FI912914A0 (fi) 1991-06-17
HUT58351A (en) 1992-02-28
GB9014546D0 (en) 1990-08-22
DE69119488T2 (de) 1996-10-02
CN1073115C (zh) 2001-10-17
JPH04279600A (ja) 1992-10-05
NO912561D0 (no) 1991-06-28
KR100198693B1 (ko) 1999-06-15
DK0465895T3 (da) 1996-06-03
PH31239A (en) 1998-06-18
CA2045761C (en) 1999-09-21
ES2087178T3 (es) 1996-07-16

Similar Documents

Publication Publication Date Title
Naruse et al. Pumilacidin, a complex of new antiviral antibiotics production, isolation, chemical properties, structure and biological activity
EP0513543B1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
CA2724785C (en) Selective caspase inhibitors and uses thereof
CZ390597A3 (cs) Peptidy a způsob jeich přípravy
FI106554B (fi) Menetelmä terapeuttisesti käyttökelpoisten WS7622A-mono- tai disulfaatin valmistamiseksi
CN101522705B (zh) 来自actinomadura namibiensis的抗菌和抗病毒肽
Hwang et al. Portage transport of sulfanilamide and sulfanilic acid
EP0674653B1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
EP1926743B1 (de) 2-(aminomethyl)-5-chlor-benzylamid-Derivate und ihre Verwendung als Hemmstoffe des Gerinnungsfaktors Xa
CA2071425C (en) Prophylactic/therapeutic composition for disseminated intravascular coagulation, or chronic respiratory tract infectious disease
EP0128249B1 (de) Antimikrobische disulfide Pro-Arzneimittel
US5190921A (en) Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments
DE69913996T2 (de) Depsipeptide, die nicht-natürliche Aminosäuren enthalten
DE69833646T2 (de) (3r)-3-amino-4-carboxybutyraldehydderivate die die il-1/beta freisetzung inhibieren
US7625870B2 (en) Peptide substance restoring respiratory organs function
JPH06509232A (ja) Ｆｒ９０１４５１物質、その製造法およびその用途
KR20020050235A (ko) 난치성 창상의 치료제
JP3092877B2 (ja) 新規ペプチドｓｎａ−１１５及びｓｎａ−１１５ｔ、その製造法及び新規ペプチド産生菌株
JPH05221872A (ja) Ｗｓ７６２２ａモノまたはジ硫酸エステルを含む医薬組成物
JPS63141998A (ja) 新規活性ペプチド
KR20000016536A (ko) 환상 뎁시펩티드 및 이를 유효성분으로 하는 의약
KR20020063932A (ko) 신규 환식 화합물
MXPA01003742A (en) Cyclic tetrapeptide compound and use thereof
JPH07173186A (ja) Ｗｓ８２４２物質